Dr Ian Hudson, Senior Advisor, Integrated Development, Global Health, Bill and Melinda Gates Foundation since 2019. Dr Ian Hudson practiced as a paediatrician before working in clinical research and development at SmithKline Beecham for 11 years. Subsequently, in 2001, he joined the MHRA as Director of Licensing and was the UK delegate to EMA’s scientific committee, CHMP, latterly its Vice Chair. Also Honorary Senior Lecturer in Clinical Pharmacology, University of London. In 2013 Dr Hudson became CEO of the MHRA until he retired in 2019. He was also a member of the EMA management Board and part of the Heads of Medicines Agencies Management Group between 2013 and 2019 and Chair of the International Coalition of Medicines Regulatory Authorities between 2016 and 2019. Awarded OBE in New Year’s Honours, 2020 for Services to Healthcare, Faculty of Pharmaceutical Medicine President’s medal for contribution to Pharmaceutical Medicine (2020) and Global Fellow in Medicines Development (2020).
